Indian markets faced pressure as the Nifty declined for a sixth consecutive trading session. Rising oil prices and ongoing West Asia conflict kept traders cautious throughout the day. The Nifty closed lower, reflecting broader market weakness and investor concerns. Domestic institutional investors provided some buying support, while FPIs also bought shares. Technical indicators suggest a period of consolidation for the indices in the near term.
Symbiotec Pharmalab sets price band for Rs 1,757 crore IPO, to open on August 24
Symbiotec Pharmalab will launch its ₹1,757-crore IPO from August 24–27, 2026, with a price band of ₹938–988 per share. The minimum bid is 15 shares,